This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: The J. David Gladstone Institutes, University of California. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 91 
1 out of 16,035 
Years Active: 2018
Title: Krystal Ann Fontaine: Innovator in Flavivirus Treatment
Introduction
Krystal Ann Fontaine is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of virology, particularly in the treatment of flavivirus infections. Her innovative work has the potential to impact public health positively.
Latest Patents
Krystal Ann Fontaine holds a patent titled "Compositions and methods for treating Dengue virus infection." This patent outlines methods for treating flavivirus infections and provides compositions for use in these methods. She has 1 patent to her name, showcasing her dedication to advancing medical science.
Career Highlights
Throughout her career, Fontaine has worked with prestigious institutions such as the J. David Gladstone Institutes and the University of California. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Melanie Ott and Andrew S. Kondratowicz. Their collaborative efforts have furthered the understanding and treatment of viral infections, enhancing the impact of their research.
Conclusion
Krystal Ann Fontaine's work in developing treatments for flavivirus infections exemplifies her commitment to innovation in the medical field. Her contributions are vital in the ongoing fight against viral diseases, and her achievements inspire future research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile